News
Programme Contacts
Royal Papworth Hospital NHS Foundation Trust, University of Cambridge
Department of Oncology
Programme Lead
Personalised blood test can detect risk of lung cancer relapse
17 Mar 2022
Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to Cambridge researchers.
UK Lung Cancer Coalition Report
25 Nov 2021
Experts fear thousands of additional UK lung cancer deaths due to pandemic, reports group chaired by our Thoracic Cancer Programme co-Lead.
Discovery of liver cell mutations gives insight into causes of liver disease
13 Oct 2021
Mutations linking liver disease with obesity and diabetes have been identified, leading to new understanding about how systemic diseases interact.
Treating a rare cancer using a precision medicine approach
6 Oct 2021
Cambridge clinical researchers have, for the first time, shown that the drug nirogacestat can be effective in treating a rare type of cancer arising from the windpipe (trachea).
ELEVATE immunotherapy trial opens
28 Sep 2021
An Addenbrooke’s doctor is leading a trial to find improved treatments for patients with advanced oesophagogastric (OG) cancer.
Fellows of the Academy of Medical Sciences 2021
12 May 2021
Four Centre members join 50 outstanding biomedical and health scientists elected to the prestigious Academy of Medical Sciences Fellowship for 2021.
Fellows of The Royal Society 2021
6 May 2021
Congratulations to Professor Julie Ahringer, Dr Peter Campbell, Professor David Rowitch and Professor Ben Simons on their election as Fellows of the Royal Society.
National Lung Matrix Trial results published
15 Jul 2020
A flagship Cancer Research UK precision medicine trial highlights the need for a new approach in treating genomically complicated cancers.
Centre members celebrate University promotions
25 Jun 2020
Congratulations to Centre members on their University promotions.
Rethinking cancer clinical trials for COVID-19 and beyond
2 Jun 2020
Gary Doherty and colleagues have published an important paper in Nature Cancer re-evaluating the processes of clinical research.
